ArticleThe Pan African medical journal2025
Tuberculosis treatment outcomes and their determinants among patients attending Hargeisa TB Hospital: a five-year retrospective study.
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Trends and determinants of tuberculosis treatment outcomes among patients at Hargeisa tuberculosis hospital, Somaliland (2019-2024): a multi-year retrospective study.BMC infectious diseases · 2026Article
- Tuberculosis in Somalia: A Narrative Review of Epidemiology, Health System Challenges, and Future Directions.Journal of healthcare leadership · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: tuberculosis (TB) is one of the major public health threats and the leading infectious disease worldwide. Assessing TB treatment outcomes and associated risk factors is crucial for effective treatment and control. This study aimed to investigate TB treatment outcomes and their related factors in Hargeisa, Somaliland. Methods: a five-year, hospital-based retrospective study was conducted at Hargeisa TB Hospital, Somaliland, from January 1 Results: the overall successful treatment outcome was 81.2%. Among all TB patients, 31.9% of males and 21.8% of females completed their treatment. Younger patients (<20 years) showed a higher likelihood of success, as indicated by adjusted odds ratio (AOR= 2.89, 95% CI: 2.35-3.56), followed by patients aged 20-40 (AOR= 2.43, 95% CI: 1.98-2.98) and 40-60 (AOR= 1.54, 95% CI: 1.23-1.93). Patients with extrapulmonary tuberculosis (EPTB) had lower odds of successful treatment compared to those with pulmonary TB (AOR= 0.75, 95% CI: 0.66-0.86). Human Immunodeficiency virus (HIV)- negative patients were more likely to achieve a successful outcome (AOR= 2.75, 95% CI: 1.82-4.10), and the likelihood of success increased progressively over the years, with 2023 showing the highest odds (AOR= 2.66, 95% CI: 2.14-3.30). Conclusion: the overall treatment outcome was below the World Health Organization (WHO) target (90%). Therefore, the study recommends improvements in TB treatment strategies, focusing on at-risk groups for less treatment success, including older individuals and HIV-coinfected TB patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.